Jahit Sacarlal
Papers
1
Total Citations
39
H-Index
1
About
Dr. Jahit Sacarlal is a leading malaria researcher whose work has fundamentally shaped our understanding of the immune response to *Plasmodium falciparum* and the performance of the world’s first licensed malaria vaccine, RTS,S. His key research areas include malaria vaccine efficacy, sero-epidemiology, and the complex interplay between host immunity and parasite life-cycle stages. Dr. Sacarlal’s major contribution lies in demonstrating that RTS,S vaccination not only targets the sporozoite and liver stages but also produces a serologic signature of decreased exposure to blood-stage parasites, a finding that redefined how partial vaccine protection is measured. This pivotal 2014 study, which has garnered 39 citations, provides critical evidence that the vaccine reduces overall parasite burden, not just initial infection. His work is instrumental in guiding the deployment and future design of malaria vaccines, offering hope for millions at risk. Through rigorous field studies, Dr. Sacarlal continues to illuminate the path toward malaria elimination, making him a vital voice in global health research.
Research Focus
Key Achievements
Top Papers
- 1